Ken Griffin Endra Life Sciences Inc. Transaction History

Citadel Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.23 - $319.0 $17,470 - $24.2 Million	75,957 New	75,957 $23,000
Q1 2022 May 16, 2022	SELL	$0.36 - $0.77 $17,822 - $38,121	-49,508 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.69 - $1.73 $23,628 - $59,242	34,244 Added 224.34%	49,508 $0
Q3 2021 Nov 15, 2021	SELL	$1.38 - $2.15 $47,736 - $74,372	-34,592 Reduced 69.38%	15,264 $26,000
Q1 2021 May 17, 2021	BUY	$0.8 - $2.85 $39,884 - $142,089	49,856 New	49,856 $130,000
Q4 2020 Feb 16, 2021	SELL	$0.69 - $0.9 $31,009 - $40,446	-44,941 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.72 - $1.04 $5,739 - $8,290	7,972 Added 21.56%	44,941 $33,000
Q2 2020 Aug 14, 2020	BUY	$0.63 - $1.1 $23,290 - $40,665	36,969 New	36,969 $36,000
Q2 2019 Aug 14, 2019	SELL	$1.02 - $2.04 $18,036 - $36,073	-17,683 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.65 - $3.29 $6,349 - $12,659	3,848 Added 27.81%	17,683 $0
Q4 2018 Feb 14, 2019	BUY	$1.5 - $5.4 $20,752 - $74,709	13,835 New	13,835 $0

Ticker NDRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 63,174,500
Market Cap $304M
Description
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.